Publikasi Scopus FKUI 2021 per tanggal 31 Oktober 2021 (739 artikel)

Qu L.G., Perera M., Lawrentschuk N., Umbas R., Klotz L.
57204687809;56544134500;57217501609;6602634832;55040556500;
Scoping review: hotspots for COVID-19 urological research: what is being published and from where?
2021
World Journal of Urology
39
9
3151
3160
1
Olivia Newton John Cancer Research Institute, Austin Health, Melbourne, VIC, Australia; Department of Surgery, University of Melbourne, Melbourne, VIC, Australia; Department of Urology, Austin Health, Heidelberg, VIC, Australia; Department of Urology, The Royal Melbourne Hospital, Melbourne, VIC, Australia; EJ Whitten Prostate Cancer Research Centre at Epworth, Melbourne, VIC, Australia; Department of Urology, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada
Qu, L.G., Olivia Newton John Cancer Research Institute, Austin Health, Melbourne, VIC, Australia, Department of Surgery, University of Melbourne, Melbourne, VIC, Australia, Department of Urology, Austin Health, Heidelberg, VIC, Australia; Perera, M., Olivia Newton John Cancer Research Institute, Austin Health, Melbourne, VIC, Australia, Department of Surgery, University of Melbourne, Melbourne, VIC, Australia; Lawrentschuk, N., Department of Surgery, University of Melbourne, Melbourne, VIC, Australia, Department of Urology, The Royal Melbourne Hospital, Melbourne, VIC, Australia, EJ Whitten Prostate Cancer Research Centre at Epworth, Melbourne, VIC, Australia; Umbas, R., Department of Urology, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; Klotz, L., Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada
Purpose: Contemporary, original research should be utilised to inform guidelines in urology relating to the COVID-19 pandemic. This comprehensive review aimed to: identify all up-to-date original publications relating to urology and COVID-19, characterise where publications were from, and outline what topics were investigated. Methods: This review utilised a search strategy that assessed five electronic databases, additional grey literature, and global trial registries. All current published, in-press, and pre-print manuscripts were included. Eligible studies were required to be original research articles of any study design, reporting on COVID-19 or urology, in any of study population, intervention, comparison, or outcomes. Included studies were reported in a narrative synthesis format. Data were summarised according to primary reported outcome topic. A world heatmap was generated to represent where included studies originated from. Results: Of the 6617 search results, 48 studies met final inclusion criteria, including 8 pre-prints and 7 ongoing studies from online registries. These studies originated from ten countries according to first author affiliation. Most studies originated from China (n = 13), followed by Italy (n = 12) and USA (n = 11). Topics of the study included pathophysiological, administrative, and clinical fields: translational (n = 14), COVID-19-related outcomes (n = 5), urology training (n = 4), telemedicine (n = 7), equipment and safety (n = 2), urology in general (n = 4), uro-oncology (n = 3), urolithiasis (n = 1), and kidney transplantation (n = 8). Conclusion: This review has outlined available original research relevant to COVID-19 and urology from the international community. This summary may serve as a guide for future research priorities in this area. ? 2020, Springer-Verlag GmbH Germany, part of Springer Nature.
COVID-19; Kidney transplantation; Telemedicine; Training; Uro-oncology; Urology
Springer Science and Business Media Deutschland GmbH
7244983
Article
Q1
1552
2143